Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Breast Cancer (Tokyo, Japan)|September 1, 2021
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT studySu-Jin Koh, Shozo Ohsumi, Masato Takahashi, et al.
Pharmacogenetics and Genomics|June 25, 2010
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen responseKazuma Kiyotani, Taisei Mushiroda, Naoya Hosono, et al.
Current Nutrition and Food Science|August 23, 2013
Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control StudyMasakazu Toi, Saya Hirota, Ai Tomotaki, et al.
British Journal of Cancer|April 3, 2020
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 studyHirofumi Mukai, Takeshi Yamaguchi, Masato Takahashi, et al.
Clinical Breast Cancer|March 9, 2021
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA StudyTsutomu Takashima, Fumikata Hara, Takayuki Iwamoto, et al.
Acta Medica Okayama|June 28, 2021
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast CancerDaisuke Takabatake, Yukiko Kajiwara, Shoichiro Ohtani, et al.
Investigational New Drugs|June 30, 2017
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational studyJunichiro Watanabe, Yoshinori Ito, Shozo Ohsumi, et al.
International Journal of Clinical Oncology|December 6, 2018
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patientsHirofumi Mukai, Chikako Shimizu, Norikazu Masuda, et al.
Clinical Breast Cancer|October 18, 2023
Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10Takayuki Iwamoto, Yukiko Kajiwara, Kengo Kawada, et al.
Human Molecular Genetics|December 20, 2011
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in JapaneseKazuma Kiyotani, Taisei Mushiroda, Tatsuhiko Tsunoda, et al.
Pageof 13